EA201692221A1 - Фармацевтическая композиция для профилактики и лечения заболеваний, связанных с повышенной активностью индуцируемой синтазы окиси азота - Google Patents

Фармацевтическая композиция для профилактики и лечения заболеваний, связанных с повышенной активностью индуцируемой синтазы окиси азота

Info

Publication number
EA201692221A1
EA201692221A1 EA201692221A EA201692221A EA201692221A1 EA 201692221 A1 EA201692221 A1 EA 201692221A1 EA 201692221 A EA201692221 A EA 201692221A EA 201692221 A EA201692221 A EA 201692221A EA 201692221 A1 EA201692221 A1 EA 201692221A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
prevention
pharmaceutical composition
nitrogen oxide
increased activity
Prior art date
Application number
EA201692221A
Other languages
English (en)
Other versions
EA030563B1 (ru
Inventor
Лига Звейниеце
Майя Дамброва
Григорийс Вайнберг
Максимс Ворона
Иварс Калвиньш
Original Assignee
Акционерное Общество "Олайнфарм"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Акционерное Общество "Олайнфарм" filed Critical Акционерное Общество "Олайнфарм"
Publication of EA201692221A1 publication Critical patent/EA201692221A1/ru
Publication of EA030563B1 publication Critical patent/EA030563B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Данное изобретение относится к новому медицинскому применению (4R)-2-(4-фенил-2-оксопирролидин-1-ил)ацетамида для лечения патологических состояний, характеризуемых повышенной экспрессией iNOS гена.
EA201692221A 2014-05-14 2015-05-14 Фармацевтическая композиция для профилактики и лечения периферической невропатии EA030563B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LVP-14-39A LV15072B (lv) 2014-05-14 2014-05-14 Farmaceitiska kompozīcija izmantošanai patoloģiska stāvokļa, kam raksturīga paaugstināta iNOS gēna ekspresija, profilaksei un ārstēšanai
PCT/IB2015/053554 WO2015173763A1 (en) 2014-05-14 2015-05-14 Pharmaceutical composition for the prevention and treatment of diseases associated with elevated inducible nitric oxide synthase

Publications (2)

Publication Number Publication Date
EA201692221A1 true EA201692221A1 (ru) 2017-05-31
EA030563B1 EA030563B1 (ru) 2018-08-31

Family

ID=53716523

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201692221A EA030563B1 (ru) 2014-05-14 2015-05-14 Фармацевтическая композиция для профилактики и лечения периферической невропатии

Country Status (7)

Country Link
US (1) US20180064687A1 (ru)
EP (1) EP3142662B1 (ru)
EA (1) EA030563B1 (ru)
GE (1) GEP20186888B (ru)
LV (1) LV15072B (ru)
UA (1) UA115010C2 (ru)
WO (1) WO2015173763A1 (ru)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV13630B (en) 2006-03-16 2007-12-20 Olainfarm As Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone
TW201408294A (zh) * 2012-07-05 2014-03-01 Merz Pharma Gmbh & Co Kgaa (r)-苯基披喇瑟盪於治療帕金森氏症之用除

Also Published As

Publication number Publication date
LV15072A (lv) 2015-11-20
UA115010C2 (uk) 2017-08-28
EP3142662A1 (en) 2017-03-22
WO2015173763A1 (en) 2015-11-19
LV15072B (lv) 2016-09-20
GEP20186888B (en) 2018-08-27
EA030563B1 (ru) 2018-08-31
US20180064687A1 (en) 2018-03-08
EP3142662B1 (en) 2020-07-08

Similar Documents

Publication Publication Date Title
IL255509B (en) Compounds as modulators of ccr2, pharmaceutical preparations containing them and their use in the treatment of diseases
PH12017501306A1 (en) Inhibitors of histone demethylases
PH12016501750A1 (en) Human plasma kallikrein inhibitors
EA201791874A1 (ru) Фторированные ингибиторы лизилоксидазоподобного фермента-2 и их применение
EA201691481A1 (ru) ИНГИБИТОРЫ C5a ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ПНЕВМОНИИ
EA201691447A1 (ru) 2-амино-3,5,5-трифтор-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1 для лечения болезни альцгеймера
PH12017500401A1 (en) Therapeutic compounds as inhibitors of the orexin-1 receptor
NZ732511A (en) Small molecule inhibitors of egfr and pi3k
MY197440A (en) Heteroamatic compounds as btk inhibitors
GEP20237457B (en) Nucleotide hemi-sulfate salt for treatment of hepatitis c virus
MX2017009417A (es) Formas solidas de acido 2-(5-(3-fluorofenil)-3-hidroxipicolinamido )acetico, composiciones y usos de las mismas.
MY174747A (en) Bace1 inhibitors
EA201690039A1 (ru) Ингибиторы rorc2 и способы их применения
ZA201707951B (en) Amide compound and use thereof as agent for the treatment and prevention of diseases caused by rna- and/or dna-containing viruses, and concomitant diseases
EA201792571A1 (ru) Терапевтическое применение l-4-хлорокинуренина
MX2019006863A (es) Inhibidores de heparanasa y uso de los mismos.
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
CL2017002229A1 (es) Inhibidores de bace1.
MD20180049A2 (ru) Фармацевтическая композиция
MX2016013588A (es) Complejo de tanato de sitagliptina.
MX2018006631A (es) Compuesto para uso en la prevencion y tratamiento de enfermedades neurodegenerativas.
EA201501130A1 (ru) Офтальмологическая фармацевтическая композиция
EA201790020A1 (ru) Соединения, фармацевтические композиции и их применение при лечении нейродегенеративных заболеваний
EA201692221A1 (ru) Фармацевтическая композиция для профилактики и лечения заболеваний, связанных с повышенной активностью индуцируемой синтазы окиси азота
KR20180085033A (ko) 피부 질환 치료용 약학적 제형 및 이의 제조 방법

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU